These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34268768)

  • 21. Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.
    Saini N; Yang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):133-143. PubMed ID: 29342230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential.
    Darini CY; Martin P; Azoulay S; Drici MD; Hofman P; Obba S; Dani C; Ladoux A
    Cell Death Dis; 2013 Jul; 4(7):e706. PubMed ID: 23828569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
    Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
    BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
    Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
    Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
    Yang Q; Zhang T; Wang C; Jiao J; Li J; Deng Y
    Eur J Pharm Biopharm; 2014 Nov; 88(3):737-45. PubMed ID: 25460146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The inhibitory effect of metformin on oral squamous cell carcinoma].
    Wang L; Wang Z; Zhao X; Ji N; Zhou Y; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jun; 50(6):360-5. PubMed ID: 26359040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
    Chen G; Xu S; Renko K; Derwahl M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sec23a inhibits the self-renewal of melanoma cancer stem cells via inactivation of ER-phagy.
    Sun Z; Liu D; Zeng B; Zhao Q; Li X; Chen H; Wang J; Rosie Xing H
    Cell Commun Signal; 2022 Mar; 20(1):22. PubMed ID: 35236368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Del Barco S; Martin-Castillo B; Menendez JA
    Breast Cancer Res Treat; 2011 Apr; 126(2):355-64. PubMed ID: 20458531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway.
    Tsai KJ; Tsai HY; Tsai CC; Chen TY; Hsieh TH; Chen CL; Mbuyisa L; Huang YB; Lin MW
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.
    Wang H; Yang M; Lin L; Ren H; Lin C; Lin S; Shen G; Ji B; Meng C
    Cell Oncol (Dordr); 2016 Feb; 39(1):35-45. PubMed ID: 26650484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin targets ovarian cancer stem cells in vitro and in vivo.
    Shank JJ; Yang K; Ghannam J; Cabrera L; Johnston CJ; Reynolds RK; Buckanovich RJ
    Gynecol Oncol; 2012 Nov; 127(2):390-7. PubMed ID: 22864111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.